DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

This work combines functional studies in model systems and examination of human tumor specimens to define a central oncogenic pathway driven by DNAJB1-PRKACA fusions in FLC. DNAJB1-PRKACA-mediated inactivation of the SIK stimulates CRTC2-p300-mediated transcription to drive tumor growth. The findings illuminate pathogenic mechanisms and inform therapeutic development.

Authors

Institutions

Publication Details

Journal
Cancer Discovery
Published
2024-09-26
DOI
https://doi.org/10.1158/2159-8290.cd-24-0634
Citations
14
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
3.99

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

Jinkai Wan, Kei Sakamoto, Marc N. Wein, Taranjit S. Gujral et al.
14 citations
Cancer Discovery
Cancer Genomics and Diagnostics
3.99
article

DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional Reprogramming

Jinkai Wan, Kei Sakamoto, Marc N. Wein, Taranjit S. Gujral, Joel Markus Vaz, Songli Zhu, Prabhat Kattel, John Dozier Gordan, Vanessa S. Silveira, Meng‐Ju Wu, Phuong Vu, Ilaria Gritti, Ashwin V. Kammula, Krushna Chandra Patra, Vindhya Vijay, Jun Qi, Giuseppe Tarantino, Robert T. Manguso, Tenna Holgersen Bryde, David Liu, Marina Chan, Nabeel Bardeesy, Christopher J. Ott, Vajira Weeresekara
article en
14 citations

Abstract

This work combines functional studies in model systems and examination of human tumor specimens to define a central oncogenic pathway driven by DNAJB1-PRKACA fusions in FLC. DNAJB1-PRKACA-mediated inactivation of the SIK stimulates CRTC2-p300-mediated transcription to drive tumor growth. The findings illuminate pathogenic mechanisms and inform therapeutic development.

Cancer DiscoveryVol. 15(2)
Broad Institute (US), University of Copenhagen (DK), Harvard University (US), University of California, San Francisco (US), Novo Nordisk Foundation (DK), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Dana-Farber Cancer Institute (US), Center for Cancer Research (US), University of Cincinnati (US), Massachusetts Institute of Technology (US), University of Cincinnati Medical Center (US)
Alex's Lemonade Stand Foundation for Childhood Cancer, American-Italian Cancer Foundation, Fibrolamellar Cancer Foundation, Novo Nordisk, Novo Nordisk Fonden, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 5%
Cancer Genomics and Diagnostics
3.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.